Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Active, Not Recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +42 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Omaha, Nebraska, United States
  • Research Site Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

NCT04083599

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +36 more
Locations
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Cancer & Blood Specialty Clinic Los Alamitos, California, United States
  • Moores Cancer Center at the UC San Diego Health San Diego, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

NCT05537740

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +30 more
Locations
  • The University of Chicago Medical Center - Hyde Park - Hematology & Oncology Chicago, Illinois, United States
  • UNC Hospitals - UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • START | San Antonio San Antonio, Texas, United States
  • South Texas Accelerated Research Therapeutics | START Rocky Mountain Region West Valley City, Utah, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery

NCT01468896

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

NCT03952585

Conditions
Basaloid Squamous Cell Carcinoma, Carcinoma, Carcinoma, Squamous Cell, +20 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 494 locations
View Trial Details
Active, Not Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

NCT05520099

Conditions
Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +72 more
Locations
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • Salinas Valley Memorial Healthcare System Salinas, California, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Memorial Health System Pembroke Pines, Florida, United States
View Trial Details
Active, Not Recruiting

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

NCT05277051

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View all 26 locations
View Trial Details

Related conditions